• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Mounting Evidence Supports Role of Bacterial Biofilms in Chronic Infections of Middle Ear and Sinuses

by Mary Beth Nierengarten • January 1, 2007

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

This phenomenon may explain why chronic sinus and ear infections seem to respond to antibiotics and then recur again after the antibiotics are stopped, he added.

You Might Also Like

  • Biofilms Likely Play Key Role in Pediatric Otitis Media and Otorrhea
  • Biofilms in Chronic Rhinosinusitis and Otitis Media
  • Biofilms in Otolaryngology: Relation to clinical disease needs more study, experts say
  • Newly Formed Society for Middle Ear Disease Aims to Educate, Advocate
Explore This Issue
January 2007

For Dr. Desrosiers, this altered phenotype of biofilms that allows bacteria to persist despite antibiotic use does not suggest that antibiotics are not needed. He emphasized the continual need for antibiotics when bacteria flare up and infection sets in, but stressed that ongoing or recurrent infections may be prevented if biofilms are eradicated.

This does not lead to less use of antibiotics, he said. At this point in time, it [biofilms] just gives us another piece of the puzzle. In terms of what it means for the patient today, it means nothing.

What the current data do support, however, is the efficacy of ventilation (tubes) or mechanical debridement (such as teeth brushing) to eradicate chronic infection. Biofilms explain why chronic middle-ear infections are so refractory to antimicrobial usage and why tubes are effective, said Dr. Post.

According to Dr. Desrosiers, tubes change the niche that the biofilm occupies by allowing oxygen to enter the middle ear and changing the local environment where biofilms exist and subsequently clearing up inner ear disease.

But if a causal relationship between biofilms and chronic infection can be made, prevention of biofilms and not eradication is suggested as the best way to reduce ongoing and recurrent infection and the frequency and amount of antibiotics used.

Martin Desrosiers, MD

Martin Desrosiers, MD

For Dr. Post, development of a probiotic approach may be the way to go to manage these chronic conditions where we populate the patient with innocuous bacteria that prevent the formation of pathogenic bacterial biofilms.

Other approaches needing further investigation may be through the use of lactoferrin and furanones, according to Dr. Chole. Lactoferrin is a protein in the body that helps defend against bacteria by trapping iron, which is a critical nutrient for bacteria. Furanones are chemicals that protect against bacteria in marine algae.

Until further evidence supports a causal link between biofilms and chronic infection, however, antibiotic use will remain the mainstay of treatment for ongoing and recurrent infections. However, as more data accumulate that demonstrate the presence of biofilms in chronic sinus and middle ear infections, a new therapeutic target aimed at prevention may eventually allow for a reduction in the use of antibiotics.

In the next two to three years you will see radical changes in the way we manage diseases, said Dr. Desrosiers. Once we do find effective strategies for dealing with biofilms, we will have a reduction in the quantity of antibiotics used.

Pages: 1 2 3 4 | Single Page

Filed Under: Articles, Clinical, Features Issue: January 2007

You Might Also Like:

  • Biofilms Likely Play Key Role in Pediatric Otitis Media and Otorrhea
  • Biofilms in Chronic Rhinosinusitis and Otitis Media
  • Biofilms in Otolaryngology: Relation to clinical disease needs more study, experts say
  • Newly Formed Society for Middle Ear Disease Aims to Educate, Advocate

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use TXA to reduce intraoperative and post-op bleeding?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • A Resident’s View of AI in Otolaryngology
  • Call for Resident Bowl Questions
  • Resident Pearls: Pediatric Otolaryngologists Share Tips for Safer, Smarter Tonsillectomies
  • A Letter to My Younger Self: Making Deliberate Changes Can Help Improve the Sense of Belonging
  • ENTtoday Welcomes Resident Editorial Board Members
  • Popular this Week
  • Most Popular
  • Most Recent
    • Office Laryngoscopy Is Not Aerosol Generating When Evaluated by Optical Particle Sizer

    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Top 10 LARY and LIO Articles of 2024

    • History of the Cochlear Implant

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Growing Use of Tranexamic Acid in Otolaryngology
    • Reconnect, Recharge, Relax, and Choose Joy This Season
    • A Resident’s View of AI in Otolaryngology
    • Faculty Mentorship of Academic Surgeons
    • CMS’ New Rule Aims to Streamline the Prior Authorization Process

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939